The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study to assess the safety and efficacy of umbralisib (TGR-1202) in pts with CLL who are intolerant to prior BTK or PI3Kδ inhibitor therapy.
 
Anthony R. Mato
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Celgene; Janssen; Prime Oncology; TG Therapeutics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); DTRM (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Regeneron (Inst); TG Therapeutics (Inst)
 
Stephen J. Schuster
Consulting or Advisory Role - Celgene; Gilead Sciences; Gilead Sciences; Merck; Nordic Nanovector; Novartis; Pharmacyclics
Research Funding - Adaptive Biotechnologies (Inst); Celgene (Inst); Gilead Sciences (Inst); Johnson & Johnson (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst)
 
Nicole Lamanna
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Juno Therapeutics; pharmacyclics; ProNAi; Roche
Research Funding - Abbvie (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); ProNAi (Inst)
 
Ian Flinn
Stock and Other Ownership Interests - RainTree Oncology Services
Research Funding - Acerta Pharma (Inst); Agios (Inst); Calithera Biosciences (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunogen (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst)
 
Jacqueline Claudia Barrientos
Research Funding - TG Therapeutics (Inst)
 
Suman Kambhampati
Consulting or Advisory Role - TG Therapeutics
Research Funding - TG Therapeutics (Inst)
 
Bruce D. Cheson
Consulting or Advisory Role - Abbvie; Acerta Pharma; Bayer; Morphosys; Pharmacyclics/Janssen; Roche/Genentech; Sunesis Pharmaceuticals; TG Therapeutics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Gilead Sciences (Inst); Roche/Genentech (Inst); TG Therapeutics (Inst)
 
Paul M. Barr
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Infinity Pharmaceuticals; Janssen; Novartis; Pharmacyclics; Seagen
Research Funding - Pharmacyclics (Inst)
 
John M. Pagel
Consulting or Advisory Role - Gilead Sciences; Pharmacyclics
 
James Andrew Reeves
Research Funding - TG Therapeutics (Inst)
 
Frederick Lansigan
Consulting or Advisory Role - Celgene; Spectrum Pharmaceuticals
Research Funding - Spectrum Pharmaceuticals (Inst)
 
Jeffrey J. Pu
Consulting or Advisory Role - Cardinal Health
Speakers' Bureau - Incyte
 
Alan P. Skarbnik
Consulting or Advisory Role - Abbvie
Speakers' Bureau - Abbvie; Genentech; Gilead Sciences; Novartis; Seagen
 
Gustavo A. Fonseca
Speakers' Bureau - Amgen; Celgene
Research Funding - Amgen (Inst); Celgene (Inst); TG Therapeutics (Inst)
 
Colleen Dorsey
Consulting or Advisory Role - TG Therapeutics
Research Funding - TG Therapeutics (Inst)
 
Eline Luning Prak
No Relationships to Disclose
 
Dana Paskalis
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Peter Sportelli
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Hari P. Miskin
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Danielle M. Brander
Honoraria - Abbvie; Genentech; Teva; TG Therapeutics
Consulting or Advisory Role - Abbvie; Genentech/Abbvie; Novartis; Pharmacyclics; Teva; TG Therapeutics
Travel, Accommodations, Expenses - Abbvie; Teva; TG Therapeutics
Other Relationship - Novartis